Novo Nordisk has submitted an unsolicited bid to buy obesity biotech Metsera out from under Pfizer, offering $6 billion ...
The agency’s decision to conceal drug names on inspection reports has prevented doctors, pharmacists and patients from ...
Pfizer Inc. (NYSE: PFE) is aware of the reckless and unprecedented proposal by Novo Nordisk A/S (NYSE: NVO) to acquire Metsera, Inc. (NASDAQ: MTSR ...
Pfizer Inc. today announced that it has filed a lawsuit against Metsera, Inc., its Board of Directors, and Novo Nordisk, S.A. in the Delaware Court of Chancery. The lawsuit asserts claims for breach ...
In August, the U.S. Food and Drug Administration approved the new COVID-19 booster shots, but with certain restrictions. Those restrictions are for people older than 6 months old but younger than ...
Press Release Nicox Provides First Half 2025 Financial Results New Drug Application (NDA) submissions for NCX 470 expected in ...
President Donald Trump made big promises to Michigan voters last year. Nine months in, he’s made progress in the Middle East, ...
Amendment includes finalized cash amount and updated CVR terms for tender offer- LAVA announces new date for extraordinary general meeting of ...
Acquisition focused on lead clinical-stage program ICT01 in acute myeloid leukemia, where data from the ongoing Phase I/II EVICTION trial showed ...
Trump is heading to the Middle East this weekend for the formal signing of the ceasefire deal he helped broker between Israel ...
The issue goes beyond Trump’s hyperbolic talk to his belief that the brute force of tariffs and shaming of companies can deliver economic results.